Abbott Sues Boehringer Unit Over Generic Zemplar
Abbott Laboratories and the Wisconsin Alumni Research Foundation slapped a Boehringer Ingelheim GmbH unit with a patent infringement suit on Thursday in Delaware seeking to block the injectable drug specialist from...To view the full article, register now.
Already a subscriber? Click here to view full article